neutral
Recently
Graphite India and Epigral slide as Krsnaa Diagnostics rallies after mixed quarterly earnings
Earnings season brought divergence among midcaps as Graphite India and Epigral declined, while Krsnaa Diagnostics, NALCO, and Torrent Pharma advanced on strong operational guidance and improving margins.
Indian midcap shares displayed sharp divergences following earnings releases. Graphite India and Epigral fell up to seven percent each after underwhelming second-quarter results, while Krsnaa Diagnostics gained eight percent on better margins and revenue growth. NALCO and Torrent Pharma also rallied up to nine percent, benefiting from stronger guidance and cost efficiency.
Analysts noted that sector-specific demand trends and input-cost variations continue to drive post-earnings volatility across industrial and healthcare counters. Broader market momentum remained positive, cushioning declines in select underperformers.